Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1195)
- Peripapillary retinal nerve fiber layer thinning in patients with progressive supranuclear palsy. (2022/06/01) ♡
- A Case of Progressive Supranuclear Palsy-like Syndrome: Aetiology Revealed. (2022/05/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies. (2022/05/01) ♡
- Energy expenditure, body composition and dietary habits in progressive supranuclear palsy. (2022/05/01) ♡
- Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy. (2022/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genetic and Epigenetic Constructs of Progressive Supranuclear Palsy. (2022/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Distinct subcortical tau burden: The tau pallido-claustral ratio separates progressive supranuclear palsy and corticobasal degeneration. (2022/03/01) ♡
- Combining current knowledge on DNA methylation-based age estimation towards the development of a superior forensic DNA intelligence tool. (2022/03/01) ♡
- Proton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multidimensional Clinical Assessment in Frontotemporal Dementia and Its Spectrum in Latin America and the Caribbean: A Narrative Review and a Glance at Future Challenges. (2022/02/16) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter regarding the article 'Progressive supranuclear palsy with marked ventricular dilatation mimicking normal pressure hydrocephalus'. (2022/02/01) ♡
- Cardiovascular autonomic dysfunction is associated with executive dysfunction and poorer quality of life in progressive supranuclear palsy-Richardson's syndrome. (2022/02/01) ♡
- Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD. (2022/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Tufted astrocyte-like glia in two autopsy cases of multiple system atrophy: Is it a concomitant neurodegenerative disorder with multiple system atrophy and progressive supranuclear palsy? (2022/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Subcutaneous apomorphine in the treatment of progressive supranuclear palsy and corticobasal syndrome: A preliminary study of 7 cases. (2022/02/01) ♡
- Computer-Aided Classification Framework of Parkinsonian Disorders Using (11)C-CFT PET Imaging. (2022/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. (2022/01/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Magnetic Resonance Imaging in Tauopathy Animal Models. (2022/01/25) ♡
- Autopsy Validation of Progressive Supranuclear Palsy-Predominant Speech/Language Disorder Criteria. (2022/01/01) ♡
- Sensitivity of Arterial Spin Labeling for Characterization of Longitudinal Perfusion Changes in Frontotemporal Dementia and Related Disorders. (2022/01/01) ♡
- Genome-wide association study and functional validation implicates JADE1 in tauopathy. (2022/01/01) ♡
- Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autopallidotomy: From Colloquial Term to Scientific Theory. (2022/01/01) ♡
- Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Incidence and morphology of secondary TDP-43 proteinopathies: Part 1. (2022/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Comprehensive ANd Multimodal Marker-based Cohort of Progressive Supranuclear Palsy(PSP) (2022-10-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Tau Imaging With JNJ067 (2022-08-31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study (2022-08-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 (2022-06-03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Complex Eye Movements in Parkinson's Disease and Related Movement Disorders (2022-05-04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Human CNS Tau Kinetics in Tauopathies (2022-04-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Biomarkers in Parkinsonian Syndromes (2022-03-31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Modifiable Variables in Parkinsonism (MVP) (2022-03-25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism (2022-03-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases (2022-03-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The MOTIVE-PSP Initiative (Progressive Supranuclear Palsy) (2022-02-11) ♡
- Depression and Apathy across Different Variants of Progressive Supranuclear Palsy. (2021/12/31) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Pain in neurodegenerative diseases with atypical parkinsonism: a systematic review on prevalence, clinical presentation, and findings from experimental studies. (2021/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. (2021/12/23) ♡
- Progressive Supranuclear Palsy: The Other Side of the Fence. (2021/12/23) ♡
- Differentiating Progressive Supranuclear Palsy and Parkinson's Disease With Head-Mounted Displays. (2021/12/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. LRRK2 signaling in neurodegeneration: two decades of progress. (2021/12/22) ♡
- Diagnostic Performance of the Magnetic Resonance Parkinsonism Index in Differentiating Progressive Supranuclear Palsy from Parkinson's Disease: An Updated Systematic Review and Meta-Analysis. (2021/12/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial. (2021/12/16) ♡
- Multiscale Entropy of Resting-State Functional Magnetic Resonance Imaging Differentiates Progressive Supranuclear Palsy and Multiple System Atrophy. (2021/12/16) ♡
- A newly described imaging finding for idiopathic normal pressure hydrocephalus: Can hummingbird sign contribute to the diagnosis? (2021/12/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Niemann-Pick type C disease with a novel intronic mutation: three Turkish cases from the same family. (2021/12/10) ♡
- Plasma Metabolite Markers of Parkinson's Disease and Atypical Parkinsonism. (2021/12/09) ♡
- Molecular Investigation of the Unfolded Protein Response in Select Human Tauopathies. (2021/12/09) ♡
- Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders. (2021/12/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.